Jazz Pharmaceuticals (JAZZ)
Develops rare-disease medicines across sleep, epilepsy and oncology.
$240.57
After hours0.00 (0.00%)
At close$240.57(−0.37%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 99.87% | 64.83M shares | |
|---|---|---|---|
| 662 holders · as of Jun 30, 2026 | |||
| Insiders | 1.51% | 978.3K shares | |
| 20 holders · as of Sep 14, 2026 | |||
| Adds to | 101.38% | ||
64.91M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 101.38%; nothing is left for Other.
13F, as of Jun 30, 2026
662 holders · 64.83M shares · 135 new positions · 378 increased · 192 reduced · 63 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.97M | 9.19% | +376.9K | Aug 7, 2026 |
| FMR LLC | 4.61M | 7.10% | +2.33M | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 3.04M | 4.68% | +53.0K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 2.73M | 4.20% | +81.3K | Aug 13, 2026 |
| Capital World Investors | 2.70M | 4.16% | +24.2K | Aug 12, 2026 |
| LSV Asset Management | 2.28M | 3.50% | −111.7K | Aug 6, 2026 |
| Franklin Resources Inc | 2.04M | 3.14% | +81.3K | Aug 13, 2026 |
| State Street Corp | 2.00M | 3.08% | +108.2K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 5.04% | 3.10M | 13G | Apr 30, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 10, 2026 | Neena M. Patilofficer: EVP & Chief Legal Officer | Sale | 1,200 | $240.94 | 47,671 |
| Sep 8, 2026 | Renee D. Galaofficer: President & CEO | Sale | 2,000 | $243.03 | 143,394 |
| Sep 1, 2026 | Bruce C. Cozadddirector | Sale | 6,000 | $250.13 | 351,875 |
| Aug 27, 2026 | Robert Iannoneofficer: EVP, Global Head of R&D & CMO | Sale · 6 lots | 76,921 | $249.70 | 65,686 |
| Aug 3, 2026 | Bruce C. Cozadddirector | Sale | 6,000 | $252.98 | 360,682 |
| Jul 1, 2026 | Bruce C. Cozadddirector | Sale | 6,000 | $240.47 | 366,682 |
| Jun 15, 2026 | Mark Douglas Smithdirector | Sale | 1,157 | $230.55 | 9,680 |
| Jun 10, 2026 | Neena M. Patilofficer: EVP & Chief Legal Officer | Sale | 1,200 | $231.83 | 51,549 |
| May 28, 2026 | Samantha Pearceofficer: EVP, Chief Commercial Officer | Sale | 6,907 | $235.41 | 50,272 |
| May 28, 2026 | Neena M. Patilofficer: EVP & Chief Legal Officer | Sale | 1,192 | $236.97 | 52,626 |
House and Senate disclosures
Not reported.